Liver I and II Flashcards

1
Q

what is the main function of the liver

A
  • synthesis and metabolism of carbohydrate, lipid, protein, drugs
  • metabolism and excretion of bilirubin and bile acids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what kind of blood supply does the liver have

A

dual supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the liver vulnerable to

A

wide variety of insults (metabolic, toxic, microbial, circulatory & neoplastic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are thr 4 primary liver diseases

A
  • viral hepatitis
  • alcohol liver disease
  • nonalcoholic fatty liver disease
  • hepatocellular carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the major causes of liver disease in West and elsewhere

A
  • West: alcohol and hepatitis C virus

- Elsewhere: hepatitis B virus, but the incidence is decreasing (vaccination)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the importance of bilirubin levels

A
  • used to diagnose and differentiate between different diseases
  • abnormal Haemoglobin in RBC O it needs to be destroyed
  • destroyed in the SPLEEN; haemoglobin –> haem and globin
  • haem –> bilirubin (unconjugated/protein bound) yellow colour. unconjugated bilirubin is toxic to the brain, it is not water soluble O if it crosses BBB it can damage the brain
  • if there is a LARGE DEGREE of RBC destruction- haemolysis, this will lead to suddenly HIGH LEVELS of unconjugated bilirubin in the blood stream
  • bilirubin is bound by ALBUMIN and transported to the liver
  • in the liver the bilirubin is CONJUGATED with glucose residues
  • it is now water soluble and is no longer toxic
  • O small amount enters blood stream (but it isn’t toxic so this is fine), some goes to gut where it will go through enterohepatic circulation, bile duct cont conjugated bilirubin
  • if there is liver cell hepatocyte damage- the liver will release both conjugated and unconjugated into blood
  • O conjugated and unconjugated will be released into blood
  • we measure both levels for diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is jaundice (icterus)

what are the types

A
  • Yellow sclerae and skin; serum bilirubin > 50μmole/L
    Types:
  • Haemolytic jaundice (pre-hepatic)
  • Congenital hyperbilirubinaemias (non-haemolytic)
  • Cholestatic jaundice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe haemolytic jaundice (pre hepatic)

A
  • INC RBC BREAKDOWN
    Investigations:
  • haemolysis
  • INC serum UNCONJUGATED bilirubin
  • normal alkaline phosphatase (ALP) and transferase
  • Bile duct obstruction results in increased synthesis of ALP by bile duct epithelial cells but as the bile duct is unaffected by haemolytic anaemia there are no high levels
  • transferase is released from hepatocytes if they are damaged, but since there is no liver damage in haemolytic anaemia there is no high transferase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe Congenital hyperbilirubinaemia

A
  • most common - Gilbert’s syndrome:
  • LOW UDP-glucuronyl transferase activity LOW conjugation of bilirubin with glucuronic acid
  • O INC in UNCOJUGATED BILIRUBIN
  • other tests normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe cholestatic jaundice

A

1) INTRAHEPATIC CHOLESTASIS:
- Abnormal bile excretion
- Bile channel obstruction

2) EXTRAHEPATIC CHOLESTASIS:
- bile flow obstruction that is distal to bile canaliculi (tubes in the liver that collect bile secretions)

Investigation:
- serum liver biochemistry
- jaundice (due to HIGH LEVELS OF CONJUGATED BILIRIRUBIN- as the bilirubin has been conjugated
- jaundice ( if there is HEPATOCYTE DAMAGE AS WELL there will be HIGH UNCONJUGATED BILIRUBIN AS WELL)
- if there is hepatitis, early in hepatitis: HIGH ALT AND AST and maybe high ALP (but less likely as cholestatic jaundice is caused by hepatocyte damge not bile duct damage)
- if there is EXTRAHEPATIC OBSTRUCTION: HIGH ALP (bile duct damage) and high (but not as high) ALT and AST
- ultrasound (dilated bile ducts in extrahepatic cholestasis ) and find the LEVEL of obstruction
- serum hepatitis markers: acute hepatitis A or B or antibodies for Hepatitis C
OTHER TESTS:
- cholestasis –> LOW VITAMIN K (it cannot be absorbed) –> INCREASED PROTHROMBIN TIME (inc time taken to clot due to less vitamin K which is req for prothrombin and other clotting factor synthesis)
- DEC liver synthetic function –> INC prothrombin time + DEC albumin production (albumin is synthesised in liver)
- autoimmune liver disease –> test serum antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is high ALP a marker for

A

bile duct damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the pathology of hepatitis

what are the types

A
  • liver cell necrosis and inflammatory infiltration

- can be acute or chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how does hepatitis present

A
  • enlarged and tender liver (may or may not be obvious)

- jaundice (may or may not be obvious)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what investigations can be done for hepatitis

A
  • SERUM TRANSFERASE IS INCREASED

either ALT (much more specific) or AST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the causes of acute hepatitis

A
  • Viruses: hepatitis viruses (most common)
  • Non-viral infection: toxoplasma gondii , etc
  • Alcohol
    Drugs: anti-TB (isoniazid), etc
  • Others: pregnancy, etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the clinical features of acute hepatitis

A
  • Usually (viral) self-limiting, return to normal structure & function
  • Occasionally progression to massive liver necrosis, even death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what investigations are used for hepatitis

A
  • HIGH SERUM ALT (best indicator of acute hepatic injury) (indicates specificity to liver)
  • prothrombin time and bilirubin conjugated and unconjugated (reflects disease severity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is chronic hepatitis

A
A sustained inflammatory disease
Causes: 
 any cause 
-Viral
-Chemical
-Autoimmune
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

describe hepatitis A

A
  • acute viral hepatitis (no chronic form)
  • caused by virus HAV
  • spread: faecal-oral
  • mechanism of liver damage: cytopathic (viruses damage cells) and immunity mediated (by T cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the clinical features

A
  • Relatively short incubation period, non-specific
  • self limiting (usually)
  • fulminant hepatitis is rare
    symptoms:
  • flu-like
    signs:
  • jaundice +/-
  • hepatomegaly (moderate)-spleen palpable (10% cases
21
Q

how can we test for hepatitis a

A
  • lab test : serum transferase IS INCREASED
22
Q

how is Hepatitis a managed/treated

A

no specific treatment

prophylaxis: immunisation
active: inactivated strain
passive: immunoglobulin

23
Q

what is the epidemiology of hepatitis B

A
  • worldwide

- prevalent in parts of Africa, Middle & Far East

24
Q

what is responsible for hepatitis b

A
  • viruses:
    HBV a DNA virus
  • HBV protein:
    core: Protein of core particle
    pre core: Pre-core can be cleave to form HBeAg (hep B antigen) which circulates in the blood
    surface: envelope protein, HBsAg is the basis of current vaccine
25
Q

what are the clinical features of hepatitis B

A
  • long incubation period
  • Chronic carriers: HBsAg >6mo.; HBeAg or viral DNA - highly infectious, risk of chronic hepatitis & cirrhosis
  • Chronic hepatitis: 3-5% acute hep B, serum liver biochemistry abnormal; liver biopsy/histology: mild inflammatory changes to cirrhosis
26
Q

how is hepatitis b spread

what is the mechanism of liver damage of hep B

A
  • parenteral (non oral- eg injection)
  • close personal contact
  • vertical (mother to baby via placenta)

Mechanism of liver damage: - Immunity-mediated (by T-cells

27
Q

what is the treatment of Hepatitis B

A
  • antiviral agents with indications eg serum HBsAg, HBV DNA
  • prophylaxis:
    avoid high risk factors
    immunisation active (vaccine) & passive
28
Q

what causes Hepatitis C
what spreads it
what is the mechanism for liver damage

A
  • Virus: HCV; non-A, non-B
  • Spread: Blood or blood products
    Other routes (eg vertical, but rare)
  • Mechanism of liver damage: Immunity-mediated (by T-cells)
29
Q

what are the special clinical features of hepatitis c

A
- Short incubation 
BUT 60-90% becoming carriers
- High risk of developing:  chronic, active hepatitis
- cirrhosis
- hepatocellular carcinoma
30
Q

how is Hep C diagnosed

A
  • by exclusion
31
Q

how is Hepatitis C managed

A
  • interferon used in acute cases to prevent chronic disease
  • Needle-stick injuries must be followed and treated early

prophylaxis:
- HCV is a RNA virus; a rapid change in envelope proteins, hence vaccine difficult

32
Q

what is liver cirrhosis

A
  • A histological diagnosis
  • End results of a variety of diseases causing chronic liver injury
  • A diffuse and irreversible process
  • Resulting from necrosis of liver cells followed by fibrosis and nodule formation
33
Q

what are the end results of cirrhosis

A
  • Impairment of liver cell function
  • Gross distortion of the liver architecture
  • Portal vein hypertension (due to blockage in portal vein caused by distortion of liver architecture)
  • Inefficient organ leads to liver failure
34
Q

what are the causes of cirrhosis

A
  • Viral, most common world-wide
    • HBV, HCV & others (Hep D)
  • Alcohol, most common in the West
  • Autoimmune hepatitis
  • Wilson’s disease (accumulation of Cu)
  • Other causes (e.g., drugs; non-alcohol fatty liver disease)
35
Q

what is the pathology of cirrhosis

A
  • FIBROSIS
  • regeneration nodules (when the liver tries to regenerate it will form nodules):
    • micronodular (small)
    • macronodular (large nodules)
    • mixed
36
Q

what are the clinical features of cirrhosis

A
  • Secondary to portal hypertension & liver cell failure
  • Jaundice, fever, loss of body hair, spider angioma, scleral icterus, palmar erythema, gynaecomastia
  • De-compensated: with severely impaired liver function & complications
  • spider angioma: liver damage means oestrogen cannot be broken down like normal
  • scleral icterus: (jaundice)
  • palmar erythema: reddish palms
  • gynaecomastia (male features become more feminine eg breast tissue growth)
  • Compensated cirrhosis: without any of complications
37
Q

what are the complications of cirrhosis

A
  • portal hypertension (variceal haemorrhage) caused by distortion of liver structure. This may cause blood in vomit due to blood vessels in oesophagus being dilated and causing haemorrhage due to high pressure caused by portal hypertension
  • Liver failure (portosystemic encephalopathy - damage to brain caused by liver damage meaning it is less able to remove ammonia also hepatorenal syndrome)
  • Hepatocellular carcinoma
  • Others (e.g. ascites- the accumulation of fluid in abdomen in peritoneuem due to portal vein hypertension where water is forced out of vessels, normally albumin maintains oncotic pressue but due to liver damage there is decreased production of albumin)
38
Q

describe liver tumours

A

The most common malignant liver tumours are metastatic, particularly those from the GI tract, breast or bronchus
- Primary liver tumours may be either benign or malignant

39
Q

what is Hepatocellular carcinoma (HCC) - hepatoma

A
  • it is the primary cancer of the liver
  • HBV and HCV carries have a very high rate of developing HCC
  • cirrhosis, particulary due to viral hepatitis
  • others:
    • Aflatoxin (fungal growth toxin on ground nuts)
    • Androgenic steroids
    • Contraceptive pill (weak association)
40
Q

what is the pathology oHepatocellular carcinoma (HCC) - hepatoma

A
  • HCC is a stepwise progression: cirrhosis –> dysplastic nodules –> tumours
  • One mass lesion, or multiple masses within the liver
  • Histological features:–Most common: liver cells cords lined by endothelial cells, thicker than normal–In well-differentiated tumour: neoplastic cells show features of normal hepatocytes
    In poorly differentiated tumour: the cells are pleomorphic with giant cells
41
Q

describe histology of Hepatocellular carcinoma (HCC) - hepatoma

A
  • cords of tumour cells separated by sinusoidal spaces (lined by endothelial cells)
  • pleomorphic tumour, giant cells
42
Q

what are the clinical symptoms of Hepatocellular carcinoma (HCC)

A

signs/ symptoms:

  • weight loss, fever, anorexia, ascites & abdominal pain
  • Cirrhosis + rapid development of above features suggests it is likely HCC
  • Cirrhosis + asymptomatic: identified by AFP & liver US
  • Cirrhosis + a focal lesion in the liver is highly likely to be HCC
43
Q

what investigations can be done for Hepatocellular carcinoma (HCC)

A
  • Serum AFP may INCREASE OR BE HIGH (in 2/3 patients)
  • Ultrasound or CT scanning: large filling defects (90% cases)
  • MRI or angiography: used when diagnostic doubt
  • Biopsy: only performed when diagnostic doubt
  • Cirrhosis & a liver mass d>2cm:HCC
44
Q

how is Hepatocellular carcinoma (HCC) managed

what is the prognosis

A
  • Surgical resection or liver transplantation: occasionally possible
  • Chemoembolisation in selected patients
  • Chemotherapy & radiotherapy unhelpful
  • Prognosis: survival often < 6months
45
Q

what is alcoholic liver disease

A
  • The most common cause of chronic liver disease in the West
  • More common in men, 4th and 5th decades, although also in 20s
  • Alcohol acts as hepatotoxin; also genetic predisposition and immune mechanisms
  • Major pathological lesions
    • Alcoholic fatty liver
    • Alcoholic hepatitis
    • Alcoholic cirrhosis
46
Q

what is alcoholic fatty liver

A
  • The most common biopsy finding in alcoholic individuals
  • Alcohol –> fat –> accumulation in hepatocytes (steatosis)
  • Symptoms usually absent
  • Hepatomegaly (enlarged liver) on examination
  • Lab test: often normal; HIGH ↑MCV of RBC (high alcohol can inhibit DNA synthesis) – heavy drinking; gamma-GT usually elevated
  • Fat disappears on cessation of alcohol intake but continued drinking can cause fibrosis and cirrhosis
47
Q

what is alcoholic hepatitis

A
  • Pathology: Liver cell necrosis, infiltration of polymophonuclear leucocytes (mainly neutrophils), MALLORY BODY REDDISH STAINING - important diagnostic feature
  • May progress to cirrhosis, particularly continued alcohol consumption
  • Presentation: a broad spectrum -asymptomatic to very ill with hepatic failure
  • Investigations: leucocytosis with elevated bilirubin and transferases (AST and ALT < 500IU/L); albumin↓ decreased, prothrombin time prolonged (inc bleeding time)

Treatment:
Supportive and adequate nutritional intake
Corticosteroids - of benefit in severe disease

48
Q

what is alcoholic cirrhosis

A
  • Final stage of liver disease from alcohol abuse
  • Destruction and fibrosis, with regenerating nodules producing a classic micronodular cirrhosis
  • Patients may be asymptomatic, although often with one of the complications of cirrhosis and signs of chronic liver disease
  • Investigation as for cirrhosis in general
    Management: directed at the complications of cirrhosis, advise patients to stop drinking for life
    Abstinence improves the 5-year survival rate